For colorectal cancer and HNSC, hardly any significant differences were found for the NAT group compared with others, possibly due to lower sample number, or less stromal content in NAT samples of colorectal cancer and HNSC compared with BRCA. The gene discussed is BRD2; the disease is colorectal cancer.